Diastolic dysfunction and altered energetics in the αMHC(403/+) mouse model of familial hypertrophic cardiomyopathy

Journal of Clinical Investigation

Volumn 101, Issue 8, 1998, Pages 1775-1783

  Spindler, Matthias ^a   Saupe, Kurt W ^a   Christe, Michael E ^a   Sweeney, H Lee ^c   Seidman, Christine E ^a   Seidman, J G ^b   Ingwall, Joanne S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioenergetics; Diastole; Hypertrophic cardiomyopathy; Myosin; Transgenic mice

Indexed keywords

CALCIUM; CREATINE PHOSPHATE; MYOSIN HEAVY CHAIN; PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; DIASTOLE; HEART LEFT VENTRICLE CONTRACTION; HEART RATE; HYPERTROPHIC CARDIOMYOPATHY; ISOLATED HEART; MALE; MISSENSE MUTATION; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 0032523194     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1940     Document Type: Article

References (21)

1. Maron, B.J., P. Spirito, K.J. Green, Y.E. Wesley, R.O. Bonow, and J. Arce. 1987. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 10:733-742.
2. Wynne, J., and E. Braunwald. 1997. The cardiomyopathies and myocarditides. In Heart Disease. 5th edition. E. Braunwald, editor. W.B. Saunders, Philadelphia. 1414-1426.
3. Seidman, C.E., and J.G. Seidman. 1995. Gene mutations that cause familial hypertrophic cardiomyopathy. In Molecular Cardiovascular Medicine. E. Haber, editor. Scientific American Press, New York. 193-210.
4. Geisterfer-Lowrance, A.A.T., M. Christe, D.A. Conner, J.S. Ingwall, F.J. Schoen, C.E. Seidman, and J.G. Seidman. 1996. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:731-734.
5. Berul, C.I., M.E. Christe, M.J. Aronovitz, C.E. Seidman, J.G. Seidman, and M.E. Mendelsohn. 1997. Electrophysiological abnormalities and arrhythmias in αMHC mutant familial hypertrophic cardiomyopathy mice. J. Clin. Invest. 99:570-576.
6. Tian, R., M.E. Christe, M. Spindler, J.C.A. Hopkins, J.M. Halow, S.A. Camacho, and J.S. Ingwall. 1997. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J. Clin. Invest. 99:745-751.
7. Hasty, P., R. Ramirez-Solis, R. Krumlauf, and A. Bradley. 1991. Introduction of a subtle mutation in the Hox-2.6 locus in embryonic stem cells. Nature. 350:243-246.
8. Chu, G., W. Luo, J.P. Slack, C. Tilgmann, W.E. Sweet, M. Spindler, K.W. Saupe, G. Boivin, C.S. Moranec, M.A. Matlib, et al. 1996. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts. Circ. Res. 78:1064-1076.
9. Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
10. Kammermeier, H. 1973. Microassay of free and total creatine from tissue extracts by combination of chromatographic and fluorometric methods. Anal. Biochem. 56:341-345.
11. Rosalki, S.B. 1967. An improved procedure for serum creatine phosphokinase determination. J. Lab. Clin. Med. 69:696-705.
12. eq of the creatine kinase reaction and other phosphate hydrolysis and phosphate transfer reactions. J. Biol. Chem. 254:6528-6537.
13. Veech, R.L., J.W.R. Lawson, N.W. Cornell, and H.A. Krebs. 1979. Cytosolic phosphorylation potential. J. Biol. Chem. 254:6538-6547.
14. Gibbs, C. 1985. The cytoplasmic phosphorylation potential. Its possible role in the control of myocardial respiration and cardiac contractility. J. Mol. Cell. Cardiol. 17:727-731.
15. Fananapazir, L., and N.D. Epstein. 1994. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Circulation. 89:22-32.
16. Buck, S.H., P.J. Konyn, and R.L. Moss. 1997. Cooperative activation of contraction of cardiac muscle by bound cross-bridges. Biophys. J. 72:A202. (Abstr.)
17. Sweeney, H.L., A.J. Straceski, L.A. Leinwand, B.A. Tikunov, and L. Faust. 1994. Heterologous expression of cardiomyopathic myosin that is defective in its actin interaction. J. Biol. Chem. 269:1603-1605.
18. Lankford, E.B., N.D. Epstein, L. Fananapazir, and H.L. Sweeney. 1995. Abnormal contractile properties of muscle fibers expressing β-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J. Clin. Invest. 95:1409-1414.
19. Marion, B.J., W.C. Roberts, and S.E. Epstein. 1982. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation. 65:1388-1394.
20. Ingwall, J. 1993. Is cardiac failure a consequence of decreased energy reserve? Circulation. 87(Suppl.):VII58-VII62.
21. Kammermeier, H. 1987. High energy phosphate of the myocardium: concentration versus free energy change. Basic Res. Cardiol. 82(Suppl. 2):31-36.